In8Bio (INAB) Long-Term Debt Repayments (2021 - 2026)
In8Bio (INAB) reported Long-Term Debt Repayments of $62,000 for Q2 2026, down 73.5% from $234,000 a year earlier and down 42.1% from the prior quarter.
In8Bio (INAB) Long-Term Debt Repayments (2021 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, In8Bio's Long-Term Debt Repayments came in at $403,000, down 54.8% year-over-year; for FY2025, it was $693,000, down 12.7% from FY2024.
- Long-Term Debt Repayments has a four-year compound annual growth rate of 6.7% (FY2021 to FY2025).
- By year, Long-Term Debt Repayments came in at $794,000 in FY2024 (-0.5%), $798,000 in FY2023 (+29.8%), $615,000 in FY2022 (+15.0%) and $535,000 in FY2021.
- The Q2 2026 figure ranks as the lowest quarterly Long-Term Debt Repayments in data going back to Q1 2021.
- Year over year, Long-Term Debt Repayments has now declined in each of the last four quarters, with an average decline of 18.3% over the last eight quarters.
- The high point for year-over-year Long-Term Debt Repayments in five years was Q3 2023 (growth of 168.2%); the low point was Q2 2026 (a decline of 73.5%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $107,000 (Q1 2026), $111,000 (Q4 2025) and $123,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 2.00 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -2.45 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 17.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | In8Bio | 25.89 Mn | 25.89 Mn | - | 62,000.00 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 62,000.00 |
| Mar 31, 2026 | 107,000.00 |
| Dec 31, 2025 | 111,000.00 |
| Sep 30, 2025 | 123,000.00 |
| Jun 30, 2025 | 234,000.00 |
| Mar 31, 2025 | 225,000.00 |
| Dec 31, 2024 | 219,000.00 |
| Sep 30, 2024 | 213,000.00 |
| Jun 30, 2024 | 174,000.00 |
| Mar 31, 2024 | 188,000.00 |
| Dec 31, 2023 | 173,000.00 |
| Sep 30, 2023 | 236,000.00 |
| Jun 30, 2023 | 214,000.00 |
| Mar 31, 2023 | 175,000.00 |
| Dec 31, 2022 | 297,000.00 |
| Sep 30, 2022 | 88,000.00 |
| Jun 30, 2022 | 95,000.00 |
| Mar 31, 2022 | 135,000.00 |
| Dec 31, 2021 | 145,000.00 |
| Sep 30, 2021 | 142,000.00 |
In8Bio Long-Term Debt Repayments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=INAB&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "long-term-debt-repayments", "ticker": "INAB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=INAB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();